A multi-center phase I/II study of melphalan, prednisone, thalidomide and defibrotide in avanced multiple myeloma patients.

被引：3
|
作者：
Palumbo, Antonio
Rus, Cecilia
Rossi, Davide
Pregno, Patrizia
Ambrosini, Maria Teresa
Avonto, Ilaria
Gay, Francesca
Cavallo, Federica
Iacobelli, Massimo
Gaidano, Gianluca
Mitsiades, Constantine
Richardson, Paul G.
Anderson, Kenneth C.
Boccadoro, Mario
机构：
[1] Univ Turin, Azienda Osped San Giovanni Battista, Div Ematol, Turin, Italy
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3560.3560
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3560
引用
收藏
页码：1016A / 1017A
页数：2
相关论文
共 50 条
  • [1] A multicenter phase I/II trial on combination of Melphalan, Prednisone, Thalidomide and Defibrotide in advanced stage Multiple Myeloma patients
    Larocca, A.
    Rossi, D.
    Pregno, P.
    Masini, L.
    Rus, C.
    Magarotto, V
    D'Agostino, F.
    Falco, P.
    Gay, F.
    Gugliotta, L.
    Gaidano, G.
    Iacobetti, M.
    Mitsiades, C.
    Richardson, P. G.
    Anderson, K. C.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 138 - 139
  • [2] Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
    Palumbo, Antonio
    Larocca, Alessandra
    Genuardi, Mariella
    Kotwica, Katarzyna
    Gay, Francesca
    Rossi, Davide
    Benevolo, Giulia
    Magarotto, Valeria
    Cavallo, Federica
    Bringhen, Sara
    Rus, Cecilia
    Masini, Luciano
    Iacobelli, Massimo
    Gaidano, Gianluca
    Mitsiades, Constantine
    Anderson, Kenneth
    Boccadoro, Mario
    Richardson, Paul
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1144 - 1149
  • [3] Efficacy and safety of melphalan, prednisone,thalidomide and defibrotide in relapsed and refractory multiple myeloma patients: Results of a multicenter phase I/II trial
    Palumbo, A.
    Larocca, A.
    Rus, C.
    Gay, E.
    Rossi, D.
    Pregno, P.
    Falco, P.
    Avonto, I.
    Magarotto, V.
    D'Agostino, F.
    Iacobelli, M.
    Gaidano, G.
    Mitsiades, C.
    Richardson, P. G.
    Anderson, K.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 94 - 94
  • [4] A phase I/II national, multi-center, open-label study of bortezomib plus melphalan and prednisone (V-MP) in elderly untreated multiple myeloma patients.
    Mateos, MV
    Blade, J
    Mediavilla, JD
    Lahuerta, JJ
    Terol, MJ
    Hernández, J
    Moro, MJ
    Bargay, J
    Ribera, JM
    de la Rubia, J
    Sureda, A
    Carrera, D
    de Arriba, F
    Palomera, L
    Hernández, M
    Laraña, JG
    Alegre, A
    Prosper, F
    Rivas, P
    Esseltine, DL
    Schenkein, D
    San Miguel, JF
    BLOOD, 2004, 104 (11) : 943A - 943A
  • [5] A phase I/II national, multi-center, open-label study of bortezomib plus melphalan and prednisone (V-MP) in elderly untreated multiple myeloma (MM) patients.
    Mateos, MV
    Hernández, M
    Díaz Mediavilla, J
    Palomera, L
    Moro, MJ
    Hernández, J
    Lahuerta, JJ
    De la Rubia, J
    Terol, MJ
    Sureda, A
    Bargay, J
    Arriba, F
    Alegre, A
    Rivas, P
    García-Laraña, J
    Ribera, JM
    Carrera, D
    Bladé, J
    Prósper, F
    Esseltine, DL
    van de Velde, H
    Schenkein, D
    San Miguel, JF
    BLOOD, 2005, 106 (11) : 232A - 232A
  • [6] A phase I/II trial on melphalan, prednisone, thalidomide and defribotide combination in relapsed/refractory multiple myeloma patients
    Palumbo, Antonio
    Larocca, Alessandra
    Rus, Cecilia
    Gay, Francesca
    Rossi, Davide
    Pregno, Patrizia
    Falco, Patrizia
    Avonto, Ilaria
    Magarotto, Valeria
    Cavallo, Federica
    Iacobelli, Massimo
    Gaidano, Gianluca
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    Boccadoro, Mario
    BLOOD, 2007, 110 (11) : 797A - 797A
  • [7] A Prospective Randomized Phase I/II Study of Lenalidomide, Melphalan, Prednisone and Thalidomide (RMPT) for Relapsed/Refractory Multiple Myeloma Patients
    Cavallo, Federica
    Larocca, Alessandra
    Petrucci, Maria Teresa
    Federico, Vincenzo
    Falcone, Antonietta Pia
    Sanpaolo, Grazia
    Canepa, Letizia
    Crugnola, Monica
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2009, 114 (22) : 1118 - 1118
  • [8] Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma
    Offidani, Massimo
    Polloni, Claudia
    Cavallo, Federica
    Liberati, Anna Marina
    Ballanti, Stelvio
    Pulini, Stefano
    Catarini, Massimo
    Alesiani, Francesco
    Corvatta, Laura
    Gentili, Silvia
    Caraffa, Patrizia
    Boccadoro, Mario
    Leoni, Pietro
    Palumbo, Antonio
    LEUKEMIA & LYMPHOMA, 2012, 53 (09) : 1722 - 1727
  • [9] Oral melphalan, prednisone and thalidomide for newly diagnosed myeloma patients.
    Palumbo, A
    Bertola, A
    Musto, P
    Nunzi, M
    De Stefano, V
    Catalano, L
    Caravita, T
    Cangialosi, C
    Bringen, S
    Boccadoro, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 569S - 569S
  • [10] Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Waage, Anders
    Gimsing, Peter
    Fayers, Peter
    Abildgaard, Niels
    Ahlberg, Lucia
    Bjorkstrand, Bo
    Carlson, Kristina
    Dahl, Inger Marie
    Forsberg, Karin
    Gulbrandsen, Nina
    Haukas, Einar
    Hjertner, Oyvind
    Hjorth, Martin
    Karlsson, Torbjorn
    Knudsen, Lene Meldgaard
    Nielsen, Johan Lanng
    Linder, Olle
    Mellqvist, Ulf-Henrik
    Nesthus, Ingerid
    Rolke, Jurgen
    Strandberg, Maria
    Sorbo, Jon Hjalmar
    Wisloff, Finn
    Juliusson, Gunnar
    Turesson, Ingemar
    BLOOD, 2010, 116 (09) : 1405 - 1412
12345